Michael K McGarrity
Mr. McGarrity, who has more than 30 years of experience in the device and diagnostic healthcare industry. Michael spent 13 years with Stryker Corporation, where he served in leadership roles in marketing and strategic development, most recently including vice president of marketing for Stryker Instruments, a $1.0 B division of the Stryker Corporation.
Currently CEO of Triple Sharp Venture Engineering, LLC. Co-Founder and former CEO of Thrive Bioscience, Inc., Sage Science, Inc., and Owl Scientific (now part of Thermo Fisher). Former VP of MJ Research (now Bio-Rad). Numerous patents and inventions. Numerous bioscience related board positions. Co-founder and former President of ActivBiotics (Lexington, MA) and ThermoCeramix (Montreal, Canada). Former Chairman, Trustee, Hallowell Awardee, of Stoneridge, a private Montessori school in Beverly, MA (now Harborlight-Stoneridge).
Donald is a C-Level executive and serial entrepreneur with an exceptional track record for creating enterprise value in mature and resource-constrained organizations. He was a managing director at both Morgan Stanley and Royal Bank of Canada holding senior capital market advisory positions in the US, Asia and Europe. Earlier he was employed with Ciba-Geigy AG in Basel Switzerland and Baxter Travenol in Deerfield, Illinois. He founded, architected and is board member of SkyLake Partners, a $50 Million real estate private equity firm based in New York.
Donald is a trustee of amfAR the Foundation for Aids Research.
Mr Bhansali is a Partner at the ICV VE Fund. Previously, after completing a 4-year stint with an investment bank, Rahul founded / co-founded 4 companies in organic food home delivery, physical commodity trade consulting, industrial safety technology, and accelerated venture investing. Recently, Mr. Bhansali was a co-founder and leader at StrongArm Tech, where he delivered a machine learning / IoT technology that is shown to produce major savings for enterprise clients.
CEO - President
Dave Bertoni is a strategic marketing professional with extensive senior management experience in multi-national corporate as well as startup environments. In the last 25-years he has brought over a dozen technical products to domestic and international markets, as well as forming and funding three high-tech startups. Mr. Bertoni founded a consulting firm, which assists medical technology and high tech firms to identify opportunities, establish clear goals, overcome difficult business challenges and achieve operational excellence.
Chief Financial Officer
Chief Financial Officer at Etiometry Inc., a predictive analytics company in healthcare. He has raised over $8M in debt and equity financings for the company. Mr. Rock has 28+ years of financial management and operations experience with a variety of large industrial companies and the last 20 years focused on life science and early stage tech companies. He was VP of Finance for Dyax Corp leading them to a successful IPO in 2000. In 2002 As a contract CFO for early stage technology and life science companies, Mr. Rock has helped raise over $45 million in private financings and successfully sold 3 businesses for his clients. He Chaired the Massachusetts Biotechnology Council’s finance committee and the Business Solutions Advisory Board for the Biotechnology Industry Organization (BIO). Mr. Rock received a BBA from University of Massachusetts – Amherst and an MBA from Rensselaer Polytechnic Institute.